Audrey Fenwick, PA
Physician Assistant · Chicago, ILNPI 1922585108
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Astellas Pharma US Inc accounts for 86.6% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $15,414 and has fallen 59.8% since, to $6,202 in 2025. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $152.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$25K
- Pfizer$1K
- Mayne Pharma Commercial LLC$541
- AbbVie$381
- Aspira Women's Health Inc$265
- Biogen$227
- plus $1K from 21 others
What the payments were for
- Consulting fees$6,71423%
- Speaking & faculty fees$12,81044%
- Travel & lodging$4,58116%
- Food & beverage$4,93317%
- Education$3611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 71 | $25,455 |
| Pfizer | 5 | $1,197 |
| Mayne Pharma Commercial LLC | 24 | $541 |
| AbbVie | 20 | $381 |
| Aspira Women's Health Inc | 4 | $265 |
| Biogen | 10 | $227 |
| Astellas Pharma Global Development | 2 | $215 |
| Radius Health, Inc. | 2 | $141 |
| Exeltis, USA Inc. | 9 | $138 |
| Hologic Sales And Service, LLC | 5 | $109 |
| Sumitomo Pharma America, Inc. | 6 | $103 |
| Seqirus USA Inc | 1 | $97 |
| Myovant Sciences Inc. | 5 | $80 |
| Organon | 5 | $77 |
| Shield Therapeutics Inc | 4 | $64 |
| Agile Therapeutics, Inc. | 3 | $44 |
| Millicent US Inc | 3 | $44 |
| Novo Nordisk | 2 | $40 |
| Therapeuticsmd, Inc. | 3 | $36 |
| Lilly USA, LLC | 2 | $30 |
| Amgen | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,399 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 243 | $18,059 |
| MyrbetriqMirabegron | 12 | $13,524 |
| Estradiol (Twice Weekly)Estradiol | 92 | $9,220 |
| ImvexxyEstradiol | 28 | $6,219 |
| PremarinEstrogens, Conjugated | 16 | $4,657 |
| ProgesteroneProgesterone, Micronized | 79 | $2,635 |
| LyllanaEstradiol | 31 | $2,276 |
| Estradiol (Once Weekly)Estradiol | 24 | $2,176 |
| Clobetasol Propionate | 29 | $1,691 |
| ValacyclovirValacyclovir Hcl | 19 | $716 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 22 | $530 |
| Ibandronate Sodium | 15 | $499 |
| Raloxifene Hcl | 18 | $405 |
| Alendronate Sodium | 41 | $254 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $25,455 | $13,52412 claims |
| Therapeuticsmd, Inc.Imvexxy | $36 | $6,21928 claims |
| PfizerPremarin | $1,197 | $4,65716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Chicago
- Andrew MastroChicago$419K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Kelly OconnorChicago$36K
- Christa CooperChicago$36K
- Amy LadewskiChicago$29K
- Lindsey KalhagenChicago$21K
- Jessica KarlChicago$18K
- Alyssa CorriganChicago$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.